Given the key roles that the PI3K/AKT/p53 signaling axis and cGAMP may play in tumor therapy, we conclude that the PI3K/AKT/p53 signaling axis and cGAMP may perform important functions in reversing OXA resistance to CRC. The gene discussed is AKT1; the disease is colorectal carcinoma.